International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Oncol Lett 10: [Related article:] 913-916, 2015; DOI: 10.3892/ol.2015.3363
Following the publication of the above article, an interested reader drew to the authors’ attention that, in Fig. 1 on p. 914, the data panels selected for Fig 1C and D showing the expression of ferroportin protein in tissue samples for moderately differentiated and poorly differentiated prostate cancer, respectively, contained overlapping information and were ultimately derived from the same original source. The authors re-examined their original data, and realized that the wrong data were selected for Fig. 1D.
The corrected version of Fig. 1, featuring the correct data panel for Fig. 1D (showing poorly-differentiated prostate cancer), is shown opposite. Note that the correction made to this figure does not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Letters for allowing them the opportunity to publish this corrigendum, and apologize to the readership for any inconvenience caused.